Lipoprotein, Low Density, Removal
Main Filters
Lipoprotein, Low Density, Removal
B.Braun Avitum AG | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
4103 | 0 | - | ||
4107 | 0 | - | ||
4109 | 0 | - | ||
4113 | 0 | - | ||
4469 | 0 | - | ||
7061007C | 0 | - | ||
7061188 | 0 | - | ||
7061192 | 0 | - | ||
706210A | 0 | - | ||
7210925 | 0 | - | ||
7210927 | 0 | - | ||
7210928 | 0 | - | ||
7210929 | 0 | - | ||
7210930 | 0 | - | ||
7210931 | 0 | - | ||
7210932 | 0 | - | ||
7210933 | 0 | - | ||
7210934 | 0 | - | ||
7211089 | 0 | - | ||
7211091 | 0 | - | ||
7211094 | 0 | - | ||
7211101 | 0 | - |
KANEKA CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
N/A | 0 | - |
KANEKA PHARMA AMERICA LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
KANEKA MA-03 | 0 | - | ||
KP-05 | 0 | - | ||
NK-M3R(U) | 0 | - | ||
NK-M3R(UL) | 0 | - |
27 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
TUBING SYSTEM FOR PLASMAPHERESIS
KANEKA PHARMA AMERICA LLC
Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
0
-
TUBING SYSTEM FOR PLASMAPHERESIS
KANEKA PHARMA AMERICA LLC
Indications for FH:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Tubing System for Plasmapheresis NK-M3R(U) is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
0
-
LIPOSORBER
KANEKA CORPORATION
Indications for FH:The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
0
-
APHERESIS MACHINE
KANEKA PHARMA AMERICA LLC
Indications for FH:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The Apheresis Machine KANEKA MA-03 is components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).
0
-
SULFLUX
KANEKA PHARMA AMERICA LLC
Indications for FH:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma.Indications for FSGS:The SULFLUX KP-05 Plasma Separator is one of three disposable device components of the LIPOSORBER® LA-15 System. The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and pediatric patients with nephrotic syndrome associated with primary focal segmental glomerulosclerosis (FSGS).